Stockscreener 앱 받기
26.03
2.11%
-0.56
시간 외 거래:
27.20
1.17
+4.49%
전일 마감가:
$26.59
열려 있는:
$30
하루 거래량:
1.93M
Relative Volume:
32.48
시가총액:
$3.18B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$25.98
$30.22
1주일 범위
$24.51
$34.47
52주 변동 폭
$24.51
$34.47
Parabilis Medicines Inc Stock (PBLS) Company Profile
Compare PBLS vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBLS
Parabilis Medicines Inc
|
26.03 | 3.06B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Parabilis Medicines Inc 주식(PBLS)의 최신 뉴스
PBLS | Parabilis Medicines, Inc. Common Insider Trading - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure - Stock Titan
Parabilis Medicines (PBLS) director converts preferred stock into common around IPO - Stock Titan
Parabilis (PBLS) director-linked LLC makes open-market buy of 12,500 shares - Stock Titan
Parabilis Medicines (PBLS) director converts Series F preferred into common in IPO - Stock Titan
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline - Yahoo Finance
Regeneron-backed Parabilis surges after record-setting IPO - MSN
Parabilis Medicines (PBLS) Stock Chart and Price History 2026 - MarketBeat
PBLS News Today | Why did Parabilis Medicines stock drop today? - MarketBeat
Parabilis Medicines prices upsized IPO at $19 per share - MSN
Parabilis Medicines prices upsized IPO at $20 per share - MSN
Current ratio of Parabilis Medicines, Inc. – NASDAQ:PBLS - TradingView
Parabilis Medicines (PBLS) Stock Price, News & Analysis - MarketBeat
Parabilis upsizes IPO seeking to raise more than $600M - MSN
PBLS SEC FilingsPARABILIS MEDICINES INC 10-K, 10-Q, 8-K Forms - Stock Titan
Rx Rundown: Incyte, Parabilis Medicines, Pfizer and more - Medical Marketing and Media
PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
PBLS: Static price chart | Parabilis Medicines, Inc. | US6989551014 - marketscreener.com
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? - Yahoo Finance
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? - The Motley Fool
Regeneron backed Parabilis seeks up to $476M in US IPO - MSN
Parabilis Medicines (PBLS) 10K Form and Latest SEC Filings 2026 - MarketBeat
Parabilis Medicines, Inc. (PBLS) Stock Price Today & Analysis - Gotrade
Parabilis (NASDAQ: PBLS) reports RA Capital-linked grant of 20,215 stock options - Stock Titan
Parabilis Medicines (PBLS) director receives 20,215 stock options at $20 strike - Stock Titan
Parabilis (PBLS) awards director 20,215 options at $20 strike - Stock Titan
Parabilis (PBLS) director granted 20,215 stock options at $20 strike - Stock Titan
PBLS Price History for Parabilis Medicines Stock - Barchart.com
Parabilis Medicines (PBLS) director receives stock options for 20,215 shares at $20 - Stock Titan
[Form 4] Parabilis Medicines, Inc. Insider Trading Activity - Stock Titan
Parabilis Medicines closes $770.5m IPO, Regeneron investment By Investing.com - Investing.com
Parabilis Medicines closes $770.5 million IPO and concurrent private placement - Investing.com Canada
Parabilis Medicines Raises About $75 Million in Private Placement With Regeneron at 90% of IPO Price - TradingView
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Regeneron backs Parabilis (PBLS) with IPO private placement and new charter - Stock Titan
Is biotech back? Kardigan tries on a $373 million IPO following Parabilis' success - The Business Journals
Parabilis Medicines Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Moomoo
Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Parabilis Medicines, Inc.Common Stock (Nasdaq:PBLS) Stock Quote - The Chronicle-Journal
Parabilis Medicines Rings the Closing Bell - Nasdaq
How to Play PBLS Stock After the Parabilis IPO - Barchart.com
Parabilis Is Now the Largest VC-Backed Biotech IPO - Morningstar
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ - Pharmaceutical Executive
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines - TradingView
Parabilis Medicines, Inc. (PBLS): IPO Prices Above Range, Opens with Massive First-Day Pop - Smartkarma
Parabilis Medicines Shares Rocket Following Record Biotech IPO - WSJ
Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO - MedCity News
Parabilis now the largest VC-backed biotech IPO - Yahoo Finance
Market Today: GM Expands Battery Business, Parabilis Medicines P - GuruFocus
Parabilis Medicines Inc (PBLS) 재무 분석
Parabilis Medicines Inc (PBLS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Parabilis Medicines Inc 주식 (PBLS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SEBULSKY ALAN | Director |
Jun 12 '26 |
Buy |
27.67 |
8,435 |
233,393 |
20,935 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 11 '26 |
Buy |
20.00 |
21,188,750 |
423,775,000 |
26,285,093 |
| SEBULSKY ALAN | Director |
Jun 11 '26 |
Buy |
20.00 |
12,500 |
250,000 |
12,500 |
2.60%
0.94%
자본화:
|
볼륨(24시간):